Azenta Sells B Medical Systems to Thelema for $63 Million

Corporate Action

โดย RTTNews·Read original

Summary · why it matters

Azenta has completed the sale of its B Medical Systems business to Thelema for a fixed purchase price of $63 million. The deal, which closed on July 1, 2026, was previously announced on December 29, 2025. B Medical Systems, a provider of cold chain medical solutions, was originally acquired by Azenta in 2022. To facilitate the transaction, Azenta Germany GmbH extended a $35 million vendor loan to Thelema, carrying 6% annual interest and maturing in three months. The company stated the divestiture will simplify its portfolio and sharpen focus on core life sciences operations.

Impact on stocks 1

Biotech & Genomic Medicine▲ · 1 stocks

▲ PositiveCapitalrelevance

Azenta sells B Medical Systems for $63M, simplifying portfolio and sharpening focus on core life sciences.

Off-coverage companies 2

B Medical SystemsPrivate± Mixed

Capitalrelevance

B Medical Systems is the divested entity; impact depends on future under Thelema, not detailed.

Thelema S.à r.l.Private± Mixed

Capitalrelevance

Thelema acquires B Medical Systems with vendor loan; strategic rationale not discussed.